カテゴリ： QYResearch, 世界, 部品/材料

生体機能性ペプチドの世界市場2025年：動物性、植物性

■ 英語タイトル：Global Biofunctional Peptide Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA0733）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA0733
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：化学＆材料
■ ページ数：91
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[生体機能性ペプチドの世界市場2025年：動物性、植物性]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は生体機能性ペプチドのグローバル市場について調査・分析し、世界の生体機能性ペプチド市場概要、メーカー別競争状況、地域別生産量、地域別消費量、タイプ別セグメント分析（動物性、植物性）、用途別セグメント分析（食品＆飲料、化粧品、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、American Peptide Company Inc.、Phermpep Co. Ltd.、ALEXIS Corporation、Ashland Inc.、Promega Corporation、Advanced Bioconcept Company、Arlak Biotech、WN Pharmaceuticals Ltd.、Anaspec Inc.、Thermo Fisher Scientific、Seagarden AS、Novo Nordisk A/S、Merck KGaAなどが含まれています。生体機能性ペプチドのグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間中の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争による影響は、生体機能性ペプチド市場規模を算出する際に考慮しました。

・生体機能性ペプチド市場の概要
- 製品の定義
- 生体機能性ペプチドの種類別セグメント
- 世界の生体機能性ペプチド市場成長率のタイプ別分析（動物性、植物性）
- 生体機能性ペプチドの用途別セグメント
- 世界の生体機能性ペプチド市場成長率の用途別分析（食品＆飲料、化粧品、その他）
- 世界市場の成長展望
- 世界の生体機能性ペプチド生産量の推定と予測（2020年-2031年）
- 世界の生体機能性ペプチド生産能力の推定と予測（2020年-2031年）
- 生体機能性ペプチドの平均価格の推定と予測（2020年-2031年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 生体機能性ペプチド市場の競争状況およびトレンド

・生体機能性ペプチドの地域別生産量
- 生体機能性ペプチド生産量の地域別推計と予測（2020年-2031年）
- 地域別生体機能性ペプチド価格分析（2020年-2025年）
- 北米の生体機能性ペプチド生産規模（2020年-2031年）
- ヨーロッパの生体機能性ペプチド生産規模（2020年-2031年）
- 中国の生体機能性ペプチド生産規模（2020年-2031年）
- 日本の生体機能性ペプチド生産規模（2020年-2031年）
- 韓国の生体機能性ペプチド生産規模（2020年-2031年）
- インドの生体機能性ペプチド生産規模（2020年-2031年）

・生体機能性ペプチドの地域別消費量
- 生体機能性ペプチド消費量の地域別推計と予測（2020年-2031年）
- 北米の生体機能性ペプチド消費量（2020年-2031年）
- 米国の生体機能性ペプチド消費量（2020年-2031年）
- ヨーロッパの生体機能性ペプチド消費量（2020年-2031年）
- アジア太平洋の生体機能性ペプチド消費量（2020年-2031年）
- 中国の生体機能性ペプチド消費量（2020年-2031年）
- 日本の生体機能性ペプチド消費量（2020年-2031年）
- 韓国の生体機能性ペプチド消費量（2020年-2031年）
- 東南アジアの生体機能性ペプチド消費量（2020年-2031年）
- インドの生体機能性ペプチド消費量（2020年-2031年）
- 中南米・中東・アフリカの生体機能性ペプチド消費量（2020年-2031年）

・種類別セグメント：動物性、植物性
- 世界の生体機能性ペプチドのタイプ別生産量（2020年-2025年）
- 世界の生体機能性ペプチドのタイプ別生産量（2024年-2029年）
- 世界の生体機能性ペプチドのタイプ別価格

・用途別セグメント：食品＆飲料、化粧品、その他
- 世界の生体機能性ペプチドの用途別生産量（2020年-2025年）
- 世界の生体機能性ペプチドの用途別生産量（2024年-2029年）
- 世界の生体機能性ペプチドの用途別価格

・主要企業のプロファイル：企業情報、製品ポートフォリオ、生産量、価格、動向
American Peptide Company Inc.、Phermpep Co. Ltd.、ALEXIS Corporation、Ashland Inc.、Promega Corporation、Advanced Bioconcept Company、Arlak Biotech、WN Pharmaceuticals Ltd.、Anaspec Inc.、Thermo Fisher Scientific、Seagarden AS、Novo Nordisk A/S、Merck KGaA

・産業チェーンと販売チャネルの分析
- 生体機能性ペプチド産業チェーン分析
- 生体機能性ペプチドの主要原材料
- 生体機能性ペプチドの販売チャネル
- 生体機能性ペプチドのディストリビューター
- 生体機能性ペプチドの主要顧客

・生体機能性ペプチド市場ダイナミクス
- 生体機能性ペプチドの業界動向
- 生体機能性ペプチド市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

The global Biofunctional Peptide market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Biofunctional Peptide is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Biofunctional Peptide is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global companies of Biofunctional Peptide include American Peptide Company Inc., Phermpep Co. Ltd., ALEXIS Corporation, Ashland Inc., Promega Corporation, Advanced Bioconcept Company, Arlak Biotech, WN Pharmaceuticals Ltd. and Anaspec Inc., etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biofunctional Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biofunctional Peptide.
The Biofunctional Peptide market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biofunctional Peptide market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biofunctional Peptide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
American Peptide Company Inc.
Phermpep Co. Ltd.
ALEXIS Corporation
Ashland Inc.
Promega Corporation
Advanced Bioconcept Company
Arlak Biotech
WN Pharmaceuticals Ltd.
Anaspec Inc.
Thermo Fisher Scientific
Seagarden AS
Novo Nordisk A/S
Merck KGaA
Segment by Type
Animal
Vegetal
Segment by Application
Food and Beverages
Cosmetics
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biofunctional Peptide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Biofunctional Peptide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Biofunctional Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Biofunctional Peptide Market Overview
1.1 Product Definition
1.2 Biofunctional Peptide Segment by Type
1.2.1 Global Biofunctional Peptide Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Animal
1.2.3 Vegetal
1.3 Biofunctional Peptide Segment by Application
1.3.1 Global Biofunctional Peptide Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Food and Beverages
1.3.3 Cosmetics
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Biofunctional Peptide Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Biofunctional Peptide Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Biofunctional Peptide Production Estimates and Forecasts (2020-2031)
1.4.4 Global Biofunctional Peptide Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Biofunctional Peptide Production Market Share by Manufacturers (2020-2025)
2.2 Global Biofunctional Peptide Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Biofunctional Peptide, Industry Ranking, 2023 VS 2024 VS 2025
2.4 Global Biofunctional Peptide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Biofunctional Peptide Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Biofunctional Peptide, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Biofunctional Peptide, Product Offered and Application
2.8 Global Key Manufacturers of Biofunctional Peptide, Date of Enter into This Industry
2.9 Biofunctional Peptide Market Competitive Situation and Trends
2.9.1 Biofunctional Peptide Market Concentration Rate
2.9.2 Global 5 and 10 Largest Biofunctional Peptide Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Biofunctional Peptide Production by Region
3.1 Global Biofunctional Peptide Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Biofunctional Peptide Production Value by Region (2020-2031)
3.2.1 Global Biofunctional Peptide Production Value Market Share by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Biofunctional Peptide by Region (2026-2031)
3.3 Global Biofunctional Peptide Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Biofunctional Peptide Production by Region (2020-2031)
3.4.1 Global Biofunctional Peptide Production Market Share by Region (2020-2025)
3.4.2 Global Forecasted Production of Biofunctional Peptide by Region (2026-2031)
3.5 Global Biofunctional Peptide Market Price Analysis by Region (2020-2025)
3.6 Global Biofunctional Peptide Production and Value, Year-over-Year Growth
3.6.1 North America Biofunctional Peptide Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Biofunctional Peptide Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Biofunctional Peptide Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Biofunctional Peptide Production Value Estimates and Forecasts (2020-2031)
4 Biofunctional Peptide Consumption by Region
4.1 Global Biofunctional Peptide Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Biofunctional Peptide Consumption by Region (2020-2031)
4.2.1 Global Biofunctional Peptide Consumption by Region (2020-2025)
4.2.2 Global Biofunctional Peptide Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Biofunctional Peptide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Biofunctional Peptide Consumption by Country (2020-2031)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Biofunctional Peptide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Biofunctional Peptide Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Biofunctional Peptide Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Biofunctional Peptide Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Biofunctional Peptide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Biofunctional Peptide Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Biofunctional Peptide Production by Type (2020-2031)
5.1.1 Global Biofunctional Peptide Production by Type (2020-2025)
5.1.2 Global Biofunctional Peptide Production by Type (2026-2031)
5.1.3 Global Biofunctional Peptide Production Market Share by Type (2020-2031)
5.2 Global Biofunctional Peptide Production Value by Type (2020-2031)
5.2.1 Global Biofunctional Peptide Production Value by Type (2020-2025)
5.2.2 Global Biofunctional Peptide Production Value by Type (2026-2031)
5.2.3 Global Biofunctional Peptide Production Value Market Share by Type (2020-2031)
5.3 Global Biofunctional Peptide Price by Type (2020-2031)
6 Segment by Application
6.1 Global Biofunctional Peptide Production by Application (2020-2031)
6.1.1 Global Biofunctional Peptide Production by Application (2020-2025)
6.1.2 Global Biofunctional Peptide Production by Application (2026-2031)
6.1.3 Global Biofunctional Peptide Production Market Share by Application (2020-2031)
6.2 Global Biofunctional Peptide Production Value by Application (2020-2031)
6.2.1 Global Biofunctional Peptide Production Value by Application (2020-2025)
6.2.2 Global Biofunctional Peptide Production Value by Application (2026-2031)
6.2.3 Global Biofunctional Peptide Production Value Market Share by Application (2020-2031)
6.3 Global Biofunctional Peptide Price by Application (2020-2031)
7 Key Companies Profiled
7.1 American Peptide Company Inc.
7.1.1 American Peptide Company Inc. Biofunctional Peptide Corporation Information
7.1.2 American Peptide Company Inc. Biofunctional Peptide Product Portfolio
7.1.3 American Peptide Company Inc. Biofunctional Peptide Production, Value, Price and Gross Margin (2020-2025)
7.1.4 American Peptide Company Inc. Main Business and Markets Served
7.1.5 American Peptide Company Inc. Recent Developments/Updates
7.2 Phermpep Co. Ltd.
7.2.1 Phermpep Co. Ltd. Biofunctional Peptide Corporation Information
7.2.2 Phermpep Co. Ltd. Biofunctional Peptide Product Portfolio
7.2.3 Phermpep Co. Ltd. Biofunctional Peptide Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Phermpep Co. Ltd. Main Business and Markets Served
7.2.5 Phermpep Co. Ltd. Recent Developments/Updates
7.3 ALEXIS Corporation
7.3.1 ALEXIS Corporation Biofunctional Peptide Corporation Information
7.3.2 ALEXIS Corporation Biofunctional Peptide Product Portfolio
7.3.3 ALEXIS Corporation Biofunctional Peptide Production, Value, Price and Gross Margin (2020-2025)
7.3.4 ALEXIS Corporation Main Business and Markets Served
7.3.5 ALEXIS Corporation Recent Developments/Updates
7.4 Ashland Inc.
7.4.1 Ashland Inc. Biofunctional Peptide Corporation Information
7.4.2 Ashland Inc. Biofunctional Peptide Product Portfolio
7.4.3 Ashland Inc. Biofunctional Peptide Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Ashland Inc. Main Business and Markets Served
7.4.5 Ashland Inc. Recent Developments/Updates
7.5 Promega Corporation
7.5.1 Promega Corporation Biofunctional Peptide Corporation Information
7.5.2 Promega Corporation Biofunctional Peptide Product Portfolio
7.5.3 Promega Corporation Biofunctional Peptide Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Promega Corporation Main Business and Markets Served
7.5.5 Promega Corporation Recent Developments/Updates
7.6 Advanced Bioconcept Company
7.6.1 Advanced Bioconcept Company Biofunctional Peptide Corporation Information
7.6.2 Advanced Bioconcept Company Biofunctional Peptide Product Portfolio
7.6.3 Advanced Bioconcept Company Biofunctional Peptide Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Advanced Bioconcept Company Main Business and Markets Served
7.6.5 Advanced Bioconcept Company Recent Developments/Updates
7.7 Arlak Biotech
7.7.1 Arlak Biotech Biofunctional Peptide Corporation Information
7.7.2 Arlak Biotech Biofunctional Peptide Product Portfolio
7.7.3 Arlak Biotech Biofunctional Peptide Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Arlak Biotech Main Business and Markets Served
7.7.5 Arlak Biotech Recent Developments/Updates
7.8 WN Pharmaceuticals Ltd.
7.8.1 WN Pharmaceuticals Ltd. Biofunctional Peptide Corporation Information
7.8.2 WN Pharmaceuticals Ltd. Biofunctional Peptide Product Portfolio
7.8.3 WN Pharmaceuticals Ltd. Biofunctional Peptide Production, Value, Price and Gross Margin (2020-2025)
7.8.4 WN Pharmaceuticals Ltd. Main Business and Markets Served
7.7.5 WN Pharmaceuticals Ltd. Recent Developments/Updates
7.9 Anaspec Inc.
7.9.1 Anaspec Inc. Biofunctional Peptide Corporation Information
7.9.2 Anaspec Inc. Biofunctional Peptide Product Portfolio
7.9.3 Anaspec Inc. Biofunctional Peptide Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Anaspec Inc. Main Business and Markets Served
7.9.5 Anaspec Inc. Recent Developments/Updates
7.10 Thermo Fisher Scientific
7.10.1 Thermo Fisher Scientific Biofunctional Peptide Corporation Information
7.10.2 Thermo Fisher Scientific Biofunctional Peptide Product Portfolio
7.10.3 Thermo Fisher Scientific Biofunctional Peptide Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Thermo Fisher Scientific Main Business and Markets Served
7.10.5 Thermo Fisher Scientific Recent Developments/Updates
7.11 Seagarden AS
7.11.1 Seagarden AS Biofunctional Peptide Corporation Information
7.11.2 Seagarden AS Biofunctional Peptide Product Portfolio
7.11.3 Seagarden AS Biofunctional Peptide Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Seagarden AS Main Business and Markets Served
7.11.5 Seagarden AS Recent Developments/Updates
7.12 Novo Nordisk A/S
7.12.1 Novo Nordisk A/S Biofunctional Peptide Corporation Information
7.12.2 Novo Nordisk A/S Biofunctional Peptide Product Portfolio
7.12.3 Novo Nordisk A/S Biofunctional Peptide Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Novo Nordisk A/S Main Business and Markets Served
7.12.5 Novo Nordisk A/S Recent Developments/Updates
7.13 Merck KGaA
7.13.1 Merck KGaA Biofunctional Peptide Corporation Information
7.13.2 Merck KGaA Biofunctional Peptide Product Portfolio
7.13.3 Merck KGaA Biofunctional Peptide Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Merck KGaA Main Business and Markets Served
7.13.5 Merck KGaA Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Biofunctional Peptide Industry Chain Analysis
8.2 Biofunctional Peptide Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Biofunctional Peptide Production Mode & Process
8.4 Biofunctional Peptide Sales and Marketing
8.4.1 Biofunctional Peptide Sales Channels
8.4.2 Biofunctional Peptide Distributors
8.5 Biofunctional Peptide Customers
9 Biofunctional Peptide Market Dynamics
9.1 Biofunctional Peptide Industry Trends
9.2 Biofunctional Peptide Market Drivers
9.3 Biofunctional Peptide Market Challenges
9.4 Biofunctional Peptide Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

List of Tables
Table 1. Global Biofunctional Peptide Market Value by Type, (US$ Million) & (2022 VS 2029)
Table 2. Global Biofunctional Peptide Market Value by Application, (US$ Million) & (2022 VS 2029)
Table 3. Global Biofunctional Peptide Production Capacity (K MT) by Manufacturers in 2024
Table 4. Global Biofunctional Peptide Production by Manufacturers (2020-2025) & (K MT)
Table 5. Global Biofunctional Peptide Production Market Share by Manufacturers (2020-2025)
Table 6. Global Biofunctional Peptide Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Biofunctional Peptide Production Value Share by Manufacturers (2020-2025)
Table 8. Global Biofunctional Peptide Industry Ranking 2023 VS 2024 VS 2025
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biofunctional Peptide as of 2022)
Table 10. Global Market Biofunctional Peptide Average Price by Manufacturers (USD/MT) & (2020-2025)
Table 11. Manufacturers Biofunctional Peptide Production Sites and Area Served
Table 12. Manufacturers Biofunctional Peptide Product Types
Table 13. Global Biofunctional Peptide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Biofunctional Peptide Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 16. Global Biofunctional Peptide Production Value (US$ Million) by Region (2020-2025)
Table 17. Global Biofunctional Peptide Production Value Market Share by Region (2020-2025)
Table 18. Global Biofunctional Peptide Production Value (US$ Million) Forecast by Region (2026-2031)
Table 19. Global Biofunctional Peptide Production Value Market Share Forecast by Region (2026-2031)
Table 20. Global Biofunctional Peptide Production Comparison by Region: 2020 VS 2024 VS 2031 (K MT)
Table 21. Global Biofunctional Peptide Production (K MT) by Region (2020-2025)
Table 22. Global Biofunctional Peptide Production Market Share by Region (2020-2025)
Table 23. Global Biofunctional Peptide Production (K MT) Forecast by Region (2026-2031)
Table 24. Global Biofunctional Peptide Production Market Share Forecast by Region (2026-2031)
Table 25. Global Biofunctional Peptide Market Average Price (USD/MT) by Region (2020-2025)
Table 26. Global Biofunctional Peptide Market Average Price (USD/MT) by Region (2026-2031)
Table 27. Global Biofunctional Peptide Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K MT)
Table 28. Global Biofunctional Peptide Consumption by Region (2020-2025) & (K MT)
Table 29. Global Biofunctional Peptide Consumption Market Share by Region (2020-2025)
Table 30. Global Biofunctional Peptide Forecasted Consumption by Region (2026-2031) & (K MT)
Table 31. Global Biofunctional Peptide Forecasted Consumption Market Share by Region (2020-2025)
Table 32. North America Biofunctional Peptide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K MT)
Table 33. North America Biofunctional Peptide Consumption by Country (2020-2025) & (K MT)
Table 34. North America Biofunctional Peptide Consumption by Country (2026-2031) & (K MT)
Table 35. Europe Biofunctional Peptide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K MT)
Table 36. Europe Biofunctional Peptide Consumption by Country (2020-2025) & (K MT)
Table 37. Europe Biofunctional Peptide Consumption by Country (2026-2031) & (K MT)
Table 38. Asia Pacific Biofunctional Peptide Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (K MT)
Table 39. Asia Pacific Biofunctional Peptide Consumption by Region (2020-2025) & (K MT)
Table 40. Asia Pacific Biofunctional Peptide Consumption by Region (2026-2031) & (K MT)
Table 41. Latin America, Middle East & Africa Biofunctional Peptide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (K MT)
Table 42. Latin America, Middle East & Africa Biofunctional Peptide Consumption by Country (2020-2025) & (K MT)
Table 43. Latin America, Middle East & Africa Biofunctional Peptide Consumption by Country (2026-2031) & (K MT)
Table 44. Global Biofunctional Peptide Production (K MT) by Type (2020-2025)
Table 45. Global Biofunctional Peptide Production (K MT) by Type (2026-2031)
Table 46. Global Biofunctional Peptide Production Market Share by Type (2020-2025)
Table 47. Global Biofunctional Peptide Production Market Share by Type (2026-2031)
Table 48. Global Biofunctional Peptide Production Value (US$ Million) by Type (2020-2025)
Table 49. Global Biofunctional Peptide Production Value (US$ Million) by Type (2026-2031)
Table 50. Global Biofunctional Peptide Production Value Share by Type (2020-2025)
Table 51. Global Biofunctional Peptide Production Value Share by Type (2026-2031)
Table 52. Global Biofunctional Peptide Price (USD/MT) by Type (2020-2025)
Table 53. Global Biofunctional Peptide Price (USD/MT) by Type (2026-2031)
Table 54. Global Biofunctional Peptide Production (K MT) by Application (2020-2025)
Table 55. Global Biofunctional Peptide Production (K MT) by Application (2026-2031)
Table 56. Global Biofunctional Peptide Production Market Share by Application (2020-2025)
Table 57. Global Biofunctional Peptide Production Market Share by Application (2026-2031)
Table 58. Global Biofunctional Peptide Production Value (US$ Million) by Application (2020-2025)
Table 59. Global Biofunctional Peptide Production Value (US$ Million) by Application (2026-2031)
Table 60. Global Biofunctional Peptide Production Value Share by Application (2020-2025)
Table 61. Global Biofunctional Peptide Production Value Share by Application (2026-2031)
Table 62. Global Biofunctional Peptide Price (USD/MT) by Application (2020-2025)
Table 63. Global Biofunctional Peptide Price (USD/MT) by Application (2026-2031)
Table 64. American Peptide Company Inc. Biofunctional Peptide Corporation Information
Table 65. American Peptide Company Inc. Specification and Application
Table 66. American Peptide Company Inc. Biofunctional Peptide Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 67. American Peptide Company Inc. Main Business and Markets Served
Table 68. American Peptide Company Inc. Recent Developments/Updates
Table 69. Phermpep Co. Ltd. Biofunctional Peptide Corporation Information
Table 70. Phermpep Co. Ltd. Specification and Application
Table 71. Phermpep Co. Ltd. Biofunctional Peptide Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 72. Phermpep Co. Ltd. Main Business and Markets Served
Table 73. Phermpep Co. Ltd. Recent Developments/Updates
Table 74. ALEXIS Corporation Biofunctional Peptide Corporation Information
Table 75. ALEXIS Corporation Specification and Application
Table 76. ALEXIS Corporation Biofunctional Peptide Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 77. ALEXIS Corporation Main Business and Markets Served
Table 78. ALEXIS Corporation Recent Developments/Updates
Table 79. Ashland Inc. Biofunctional Peptide Corporation Information
Table 80. Ashland Inc. Specification and Application
Table 81. Ashland Inc. Biofunctional Peptide Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 82. Ashland Inc. Main Business and Markets Served
Table 83. Ashland Inc. Recent Developments/Updates
Table 84. Promega Corporation Biofunctional Peptide Corporation Information
Table 85. Promega Corporation Specification and Application
Table 86. Promega Corporation Biofunctional Peptide Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. Promega Corporation Main Business and Markets Served
Table 88. Promega Corporation Recent Developments/Updates
Table 89. Advanced Bioconcept Company Biofunctional Peptide Corporation Information
Table 90. Advanced Bioconcept Company Specification and Application
Table 91. Advanced Bioconcept Company Biofunctional Peptide Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 92. Advanced Bioconcept Company Main Business and Markets Served
Table 93. Advanced Bioconcept Company Recent Developments/Updates
Table 94. Arlak Biotech Biofunctional Peptide Corporation Information
Table 95. Arlak Biotech Specification and Application
Table 96. Arlak Biotech Biofunctional Peptide Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 97. Arlak Biotech Main Business and Markets Served
Table 98. Arlak Biotech Recent Developments/Updates
Table 99. WN Pharmaceuticals Ltd. Biofunctional Peptide Corporation Information
Table 100. WN Pharmaceuticals Ltd. Specification and Application
Table 101. WN Pharmaceuticals Ltd. Biofunctional Peptide Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. WN Pharmaceuticals Ltd. Main Business and Markets Served
Table 103. WN Pharmaceuticals Ltd. Recent Developments/Updates
Table 104. Anaspec Inc. Biofunctional Peptide Corporation Information
Table 105. Anaspec Inc. Specification and Application
Table 106. Anaspec Inc. Biofunctional Peptide Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Anaspec Inc. Main Business and Markets Served
Table 108. Anaspec Inc. Recent Developments/Updates
Table 109. Thermo Fisher Scientific Biofunctional Peptide Corporation Information
Table 110. Thermo Fisher Scientific Specification and Application
Table 111. Thermo Fisher Scientific Biofunctional Peptide Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Thermo Fisher Scientific Main Business and Markets Served
Table 113. Thermo Fisher Scientific Recent Developments/Updates
Table 114. Seagarden AS Biofunctional Peptide Corporation Information
Table 115. Seagarden AS Specification and Application
Table 116. Seagarden AS Biofunctional Peptide Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Seagarden AS Main Business and Markets Served
Table 118. Seagarden AS Recent Developments/Updates
Table 119. Novo Nordisk A/S Biofunctional Peptide Corporation Information
Table 120. Novo Nordisk A/S Specification and Application
Table 121. Novo Nordisk A/S Biofunctional Peptide Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Novo Nordisk A/S Main Business and Markets Served
Table 123. Novo Nordisk A/S Recent Developments/Updates
Table 124. Merck KGaA Biofunctional Peptide Corporation Information
Table 125. Merck KGaA Specification and Application
Table 126. Merck KGaA Biofunctional Peptide Production (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Merck KGaA Main Business and Markets Served
Table 128. Merck KGaA Recent Developments/Updates
Table 129. Key Raw Materials Lists
Table 130. Raw Materials Key Suppliers Lists
Table 131. Biofunctional Peptide Distributors List
Table 132. Biofunctional Peptide Customers List
Table 133. Biofunctional Peptide Market Trends
Table 134. Biofunctional Peptide Market Drivers
Table 135. Biofunctional Peptide Market Challenges
Table 136. Biofunctional Peptide Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biofunctional Peptide
Figure 2. Global Biofunctional Peptide Market Value by Type, (US$ Million) & (2022 VS 2029)
Figure 3. Global Biofunctional Peptide Market Share by Type: 2022 VS 2029
Figure 4. Animal Product Picture
Figure 5. Vegetal Product Picture
Figure 6. Global Biofunctional Peptide Market Value by Application, (US$ Million) & (2022 VS 2029)
Figure 7. Global Biofunctional Peptide Market Share by Application: 2022 VS 2029
Figure 8. Food and Beverages
Figure 9. Cosmetics
Figure 10. Others
Figure 11. Global Biofunctional Peptide Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Biofunctional Peptide Production Value (US$ Million) & (2020-2031)
Figure 13. Global Biofunctional Peptide Production Capacity (K MT) & (2020-2031)
Figure 14. Global Biofunctional Peptide Production (K MT) & (2020-2031)
Figure 15. Global Biofunctional Peptide Average Price (USD/MT) & (2020-2031)
Figure 16. Biofunctional Peptide Report Years Considered
Figure 17. Biofunctional Peptide Production Share by Manufacturers in 2024
Figure 18. Biofunctional Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. The Global 5 and 10 Largest Players: Market Share by Biofunctional Peptide Revenue in 2024
Figure 20. Global Biofunctional Peptide Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 21. Global Biofunctional Peptide Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 22. Global Biofunctional Peptide Production Comparison by Region: 2020 VS 2024 VS 2031 (K MT)
Figure 23. Global Biofunctional Peptide Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 24. North America Biofunctional Peptide Production Value (US$ Million) Growth Rate (2020-2031)
Figure 25. Europe Biofunctional Peptide Production Value (US$ Million) Growth Rate (2020-2031)
Figure 26. China Biofunctional Peptide Production Value (US$ Million) Growth Rate (2020-2031)
Figure 27. Japan Biofunctional Peptide Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Global Biofunctional Peptide Consumption by Region: 2020 VS 2024 VS 2031 (K MT)
Figure 29. Global Biofunctional Peptide Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 30. North America Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 31. North America Biofunctional Peptide Consumption Market Share by Country (2020-2031)
Figure 32. Canada Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 33. U.S. Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 34. Europe Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 35. Europe Biofunctional Peptide Consumption Market Share by Country (2020-2031)
Figure 36. Germany Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 37. France Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 38. U.K. Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 39. Italy Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 40. Russia Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 41. Asia Pacific Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 42. Asia Pacific Biofunctional Peptide Consumption Market Share by Regions (2020-2031)
Figure 43. China Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 44. Japan Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 45. South Korea Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 46. China Taiwan Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 47. Southeast Asia Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 48. India Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 49. Latin America, Middle East & Africa Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 50. Latin America, Middle East & Africa Biofunctional Peptide Consumption Market Share by Country (2020-2031)
Figure 51. Mexico Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 52. Brazil Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 53. Turkey Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 54. GCC Countries Biofunctional Peptide Consumption and Growth Rate (2020-2025) & (K MT)
Figure 55. Global Production Market Share of Biofunctional Peptide by Type (2020-2031)
Figure 56. Global Production Value Market Share of Biofunctional Peptide by Type (2020-2031)
Figure 57. Global Biofunctional Peptide Price (USD/MT) by Type (2020-2031)
Figure 58. Global Production Market Share of Biofunctional Peptide by Application (2020-2031)
Figure 59. Global Production Value Market Share of Biofunctional Peptide by Application (2020-2031)
Figure 60. Global Biofunctional Peptide Price (USD/MT) by Application (2020-2031)
Figure 61. Biofunctional Peptide Value Chain
Figure 62. Biofunctional Peptide Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation

※参考情報

生体機能性ペプチド（Biofunctional Peptide）とは、特定の生理活性を持ち、さまざまな生物学的作用を引き起こす短鎖のアミノ酸連鎖のことを指します。これらのペプチドは、特に健康や栄養において重要な役割を果たしており、食品や医薬品、化粧品など多岐にわたる分野で注目されています。本稿では、生体機能性ペプチドの概念についてその定義や特徴、種類、用途、関連技術などを詳しく解説いたします。

生体機能性ペプチドの定義としては、通常、2から50程度のアミノ酸残基から構成されるペプチドであり、特定の生理活性を示すことが特徴です。これらのペプチドは、食物由来のタンパク質から消化や酵素処理によって生成されることが多く、食品中に自然に存在する場合もあれば、合成される場合もあります。特に、乳製品、魚、肉、大豆などの食品において多くの生体機能性ペプチドが発見されています。

特徴としては、まずその生理活性が挙げられます。生体機能性ペプチドは、抗酸化作用、免疫調整作用、抗高血圧作用、抗菌作用、抗炎症作用など、多岐にわたる生理活性を持つことがあります。また、これらのペプチドは体内で速やかに吸収され、生理活性を発揮するため、機能性食品やサプリメントとしての利用が期待されています。さらに、ペプチドは構造が小さいため、体内で特定の受容体に結合しやすく、治療ターゲットとしても注目されています。

生体機能性ペプチドはその性質からいくつかの種類に分類することができます。ひとつは、免疫機能を調節するペプチドであり、これらは感染症やアレルギーの予防効果が期待されています。次に、ホルモン様作用を持つペプチドがあり、インスリン様ペプチドや成長ホルモン様ペプチドなどがあります。また、抗酸化ペプチドや抗高血圧ペプチドも重要なカテゴリーで、これらは生活習慣病の予防に寄与することが示されています。

用途の面では、生体機能性ペプチドは健康食品やサプリメントとして広く利用されています。例えば、高血圧の改善を目的とした機能性食品では、血圧を下げる効果があるとされるペプチドが取り入れられていることがあります。また、筋肉の合成を促進するためのスポーツサプリメントにも、特定の機能性ペプチドが含まれています。さらには、皮膚の健康を促進するための化粧品にも、保湿や抗老化作用を持つペプチドが配合されており、美容分野での応用も進んでいます。

関連技術に関しては、ペプチドの特定や抽出に用いる技術が進化しています。例えば、タンパク質の分解によって得られるペプチドを分析するための質量分析や、ペプチドの生理活性を評価するためのin vitro試験やin vivo試験が行われています。また、遺伝子操作技術を用いて生理活性ペプチドを合成する研究も盛んであり、これにより従来のペプチドよりも高い活性を持つ新しいペプチドの開発が進められています。

さらに、最近ではコンピュータ科学を駆使したバイオインフォマティクスの技術も利用されており、大量のデータから生体機能性ペプチドを予測し、効率的に新規ペプチドの設計が行われるようになっています。これにより、特定の疾患に対するターゲット型のペプチドの発見が加速しています。

以上のように、生体機能性ペプチドはその多様な生理活性により、健康や美容、医療の分野で重要な役割を果たしています。今後、さらなる研究と技術の進展によって、より多くの生体機能性ペプチドが解明され、新しい機能性食品や治療法の開発につながることが期待されます。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 自動ペプチド合成装置の世界市場2025年：全自動型、半自動型、手動型
  • Lys（1-デオキシフルクトシル）の世界市場2025年：0.97、0.99
  • ペプチド分析ツールの世界市場2025年：全自動解析ツール、半自動解析ツール
  • 組換えペプチドの世界市場2025年：グルカゴン、カルシトニン、その他
  • C-ペプチド検査キットの世界市場2025-2031：化学発光免疫測定法、時間分解免疫測定法
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA0733 )"生体機能性ペプチドの世界市場2025年：動物性、植物性" (英文：Global Biofunctional Peptide Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。